I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Trzaskoma, B.
34
results:
Search for persons
X
Format
Online (34)
Mediatypes
Articles (Online) (31)
OpenAccess-fulltext (3)
Sorted by: Relevance
Sorted by: Year
?
1
TIME TO SLEEP IMPROVEMENT IN PATIENTS WITH CHRONIC SPONTANE..:
Mosnaim, G.
;
Holden, M.
;
Trzaskoma, B.
..
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S36 , 2023
Link:
https://doi.org/10.1016/..
?
2
IMPACT OF BASELINE ANGIOEDEMA AND IGE ON RESPONSE TO OMALIZ..:
Casale, T.
;
Trzaskoma, B.
;
Holden, M.
..
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S35 , 2023
Link:
https://doi.org/10.1016/..
?
3
IMPACT OF BASELINE CHARACTERISTICS ON LONG-TERM RESPONSE FO..:
Katial, R.
;
Creasy, B.
;
Trzaskoma, B.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S53 , 2023
Link:
https://doi.org/10.1016/..
?
4
TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PAT..:
Casale, T.
;
Holden, M.
;
Trzaskoma, B.
.
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S26-S27 , 2022
Link:
https://doi.org/10.1016/..
?
5
IMPROVEMENTS IN SELECT PATIENT-REPORTED OUTCOMES ARE SIMILA..:
Chase, N.
;
Trzaskoma, B.
;
Holweg, C.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S39 , 2022
Link:
https://doi.org/10.1016/..
?
6
PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FRO..:
Mosnaim, G.
;
Casale, T.
;
Holden, M.
..
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S10 , 2022
Link:
https://doi.org/10.1016/..
?
7
EFFECT OF SEX ON RESPONSE TO OMALIZUMAB IN PATIENTS WITH AS..:
Holweg, C.
;
Steinke, J.
;
Trzaskoma, B.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S38-S39 , 2022
Link:
https://doi.org/10.1016/..
?
8
Response to omalizumab using patient enrichment criteria fr..:
Casale, T. B.
;
Chipps, B. E.
;
Rosén, K.
...
Allergy. 73 (2017) 2 - p. 490-497 , 2017
Link:
https://doi.org/10.1111/..
?
9
Response to omalizumab using patient enrichment criteria fr..:
Casale, T. B
;
Chipps, B. E
;
Rosén, K
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813202/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
10
Does angioedema in patients with chronic spontaneous urtica..:
Casale, Thomas B.
;
Trzaskoma, Benjamin
;
Holden, Michael
..
World Allergy Organization Journal. 17 (2024) 8 - p. 100943 , 2024
Link:
https://doi.org/10.1016/..
?
11
Effectiveness of omalizumab across different dosing regimen..:
Chase, Nicole M.
;
Littlejohn, Monica
;
Holweg, Cecile T.J.
...
Respiratory Medicine. 223 (2024) - p. 107537 , 2024
Link:
https://doi.org/10.1016/..
?
12
Characteristics of patients with chronic spontaneous urtica..:
Mosnaim, Giselle
;
Casale, Thomas B.
;
Holden, Michael
..
The Journal of Allergy and Clinical Immunology: In Practice. , 2024
Link:
https://doi.org/10.1016/..
?
13
Omalizumab Effectiveness by Biomarker Status in Patients wi..:
Casale, Thomas B.
;
Luskin, Allan T.
;
Busse, William
...
The Journal of Allergy and Clinical Immunology: In Practice. 7 (2019) 1 - p. 156-164.e1 , 2019
Link:
https://doi.org/10.1016/..
?
14
Impact Of Omalizumab On Patient Reported Outcomes In Chroni..:
Casale, Thomas B.
;
Murphy, Thomas R.
;
Holden, Michael
...
Journal of Allergy and Clinical Immunology. 141 (2018) 2 - p. AB405 , 2018
Link:
https://doi.org/10.1016/..
?
15
The XTEND-CIU study: Long-term use of omalizumab in chronic..:
Maurer, Marcus
;
Kaplan, Allen
;
Rosén, Karin
...
Journal of Allergy and Clinical Immunology. 141 (2018) 3 - p. 1138-1139.e7 , 2018
Link:
https://doi.org/10.1016/..
1-15